Markets

Tuya Smart launches “Hey Tuya,” a next-gen AI life assistant designed for ubiquitous integration into daily routines, mirroring J.A.R.V.I.S. This multi-device system learns user habits and anticipates needs, offering proactive support across home, work, and personal life. Powered by Tuya’s proprietary PAE engine and a global network, Hey Tuya aims to advance physical AI by enabling seamless interaction and control of smart devices, fostering an open ecosystem for AIoT innovation.

Battery X Metals strengthens its Advisory Board with the appointment of Jeffrey Greenberg, a former Skechers executive. Greenberg’s expertise in global brand scaling and capital markets will support the company’s advancements in next-generation lithium-ion battery technology. Battery X Metals is focusing on a patent-pending rebalancing platform that significantly restores EV battery range, and a material recovery process with high graphite and oxide yields, aiming for a sustainable battery lifecycle.

Mountain Valley MD Holdings Inc. (MVMD) achieved significant progress in 2025 across its nutraceutical, agriculture, and animal health sectors. Its patented Quicksome™ technology is enhancing nutraceutical product efficacy and development. In agriculture, the Agrarius™ technology demonstrated substantial crop yield increases and improved plant health in trials across various crops and regions. For animal health, MVMD is strategically reviewing its Soluvec™ 1% licensing model to optimize commercialization of its ivermectin formulation.

Everybody Loves Languages Corp. (ELLC) has entered a business combination agreement with ELL Ventures Ltd. (EV) in a cash-out merger transaction. ELLC shareholders, excluding EV, will receive $0.085 per share, and ELLC is expected to be delisted from the TSX Venture Exchange. The transaction, led by key company executives Gali Bar-Ziv and Khurram Qureshi, is a related-party transaction subject to regulatory approval and shareholder vote. An independent committee has unanimously recommended the transaction, which is financed by a term loan and capital contributions from EV principals.

Max Resource Corp. is implementing a 4-for-1 share consolidation to boost investor appeal and a $3.4 million private placement to fund exploration. The company boasts promising gold-silver projects in Colombia with high-grade assays and a copper-silver project funded by Freeport-McMoRan. Additionally, a proposed transaction for its Brazilian iron ore project with Bolt Metals Corp. is underway. These strategic moves aim to enhance shareholder value and accelerate project development.

SMX is pivoting from technology validation to a scalable, capital-efficient deployment model. By integrating into existing workflows rather than building proprietary manufacturing, the company is prioritizing efficient capital use over sheer revenue growth. Having overcome its most capital-intensive validation phase, SMX now leverages its core technology for broader market access with diminishing incremental costs. This approach promises an asymmetric valuation profile, with bounded downside risk and expanding upside potential driven by operating leverage and network effects, positioning SMX as an emerging infrastructure provider.

Gold is transforming from a commodity to a subject of intense scrutiny, demanding accountability and transparency. SMX and FinGo are pioneering solutions that embed immutable verification directly into gold at a molecular level and verify individuals involved in the supply chain. This dual approach, exemplified by partnerships like the one with Bougainville Refinery, moves beyond traditional audits to create a dynamic, traceable system, making demonstrable proof essential for market access.

Teva Pharmaceutical Industries has received upgraded credit ratings and a positive outlook from S&P and Moody’s. These actions reflect the company’s successful “Pivot to Growth” strategy, evidenced by consistent deleveraging and a return to revenue growth. Strong performance in branded medicines and upcoming biosimilar launches are key drivers, offsetting generics headwinds. This signifies Teva’s progress toward financial health and potentially investment-grade status.

TNL Mediagene has secured continued listing on The Nasdaq Capital Market, contingent on meeting bid price requirements by January 7, 2026, following a successful appeal. This Asia-focused digital media conglomerate, formed from a merger of The News Lens and Mediagene Inc., offers diverse content and AI-driven advertising services. The company is implementing a reverse stock split to comply with Nasdaq’s $1 bid price rule.

Himax Technologies will debut a Drone AI Imaging Solution at CES 2026. This integrated system, a collaboration between Himax’s Liqxtal and iCatch Technology, combines Liqxtal’s advanced 20x optical zoom EO/IR camera with iCatch’s powerful edge-AI vision SoC. It offers real-time aerial intelligence, object recognition, and threat detection with on-device processing, enhancing applications in surveillance, photography, and inspections while ensuring stability and seamless integration.